Measles Elimination Status Statistics in US | Key Facts

Measles Elimination Status in the US 2026

Measles elimination is one of the most celebrated achievements in American public health history — and as of April 2026, it is also one of the most actively threatened. The United States officially declared measles eliminated in 2000, the result of a sustained, decades-long effort built on childhood vaccination, strong disease surveillance, and rapid outbreak response. For more than two decades, that status held, even as small outbreaks periodically flared and were contained. But a confluence of forces — declining MMR vaccination rates, widening pockets of vaccine hesitancy, pandemic-era disruptions to routine immunization, and a surge in global measles activity — has now pushed the US to the edge of losing that status entirely. In 2025, the United States recorded 2,288 confirmed measles cases, the highest single-year total since 1991 and a figure that shocked public health officials who had spent years guarding the elimination benchmark. The crisis has not subsided: as of April 16, 2026, the CDC has already confirmed 1,748 measles cases in 2026 alone — a pace that is running significantly ahead of 2025 at the same point in the year.

The measles elimination statistics for the United States in 2026 tell a story that is both medically precise and deeply human. Behind every case number is an unvaccinated child in a community where misinformation outpaced public health outreach, or a family in an undervaccinated county where herd immunity collapsed just enough for the virus to find a foothold. The South Carolina outbreak — which began in October 2025 and had reached 997 confirmed cases in Spartanburg County as of April 14, 2026 — is now the single largest measles outbreak in the United States since elimination was declared, surpassing every previous post-2000 outbreak by a wide margin. Meanwhile, the Pan American Health Organization (PAHO) formally invited the United States to a review meeting on April 13, 2026 to assess whether the country retains its official measles elimination status. The outcome of that assessment, combined with the CDC’s own ongoing analysis, will determine whether 25 years of one of America’s greatest public health achievements can be preserved — or whether 2026 marks the year the US lost it.

Interesting Facts About Measles Elimination Status in the US

Sources: CDC — Measles Cases and Outbreaks (updated April 16, 2026, cdc.gov/measles/data-research); CDC — History of Measles (cdc.gov); CDC MMWR — Measles Update, April 17, 2025; CDC — Chapter 7, Manual for Surveillance of Vaccine-Preventable Diseases

These numbers land hard once you absorb what they actually mean. The herd immunity threshold of 95% two-dose MMR coverage is not an arbitrary bureaucratic target — it is the mathematically derived point at which measles, one of the most contagious pathogens on earth, runs out of susceptible hosts before it can sustain a chain of transmission. When kindergartner MMR coverage drops from 95.2% in 2019–2020 to 92.5% in 2024–2025, it doesn’t look dramatic on paper. But it translates to 286,000 unprotected children in schools across the country, each one a potential case and a potential amplifier in an outbreak. The virus exploits exactly those gaps, and it moves fast: one person with measles will infect up to 90% of unprotected close contacts. For comparison, the flu’s secondary attack rate is roughly 5–15%. This extraordinary contagiousness is why the measles elimination threshold is set so high and why even small coverage declines carry such outsized public health consequences.

The economic framing of the 2025 outbreak — a $244.2 million estimated burden at a cost of $104,629 per case — adds a dimension to the crisis that purely clinical statistics sometimes miss. Every measles case generates costs across the response chain: laboratory testing, case investigation, contact tracing, quarantine support, outbreak control, medical treatment, and lost productivity for families managing sick children. The three deaths confirmed in 2025, the first US measles fatalities since 2015, represent the most irreversible cost of all. Two were children in Texas; one was an unvaccinated adult in New Mexico. The 1% MMR coverage drop scenario modeled by the Common Health Coalition — projecting 17,000 cases, 4,000 hospitalizations, and 36 deaths per year — is not a worst-case fantasy. It is a calibrated warning about where the trajectory leads if coverage continues to erode, and the 2025–2026 outbreak statistics suggest that warning is no longer hypothetical.

US Measles Cases & Outbreak Statistics 2025–2026

Sources: CDC — Measles Cases and Outbreaks (updated April 16, 2026, cdc.gov/measles/data-research); ASTHO — “Understanding Current US Measles Outbreaks and Elimination Status” (January 21, 2026); CDC MMWR — “Measles Update — US, January 1–April 17, 2025”

The case trajectory from 2024 to 2026 is one of the starkest statistical escalations in recent US public health history. Going from 285 confirmed cases in all of 2024 to 2,288 in 2025 represents a 703% year-over-year increase — a figure that, even in disease surveillance contexts where rapid changes are common, stopped public health officials in their tracks. The 49 outbreaks in 2025 — compared to just 16 in 2024 — signal that this was not a single large event but a nationwide problem driven by structural vulnerability. The 88% of cases being outbreak-associated in 2025 confirms that community transmission — not just individual imported cases — was driving the crisis. When measles cases are mostly linked to outbreaks rather than isolated imported events, it demonstrates that the virus is finding and exploiting unvaccinated communities, not just arriving from abroad and being rapidly extinguished.

The 2026 data as of April 16 makes an already serious picture more acute. The 1,748 confirmed cases by mid-April of 2026 represents a pace that Johns Hopkins public health researchers confirmed was running ahead of where 2025 was at the same point in the year. The 94% outbreak-associated rate for 2026 cases — with 1,249 of those cases linked to outbreaks that started in 2025 and simply carried forward — is the statistical fingerprint of what the CDC defines as sustained endemic transmission: the very criterion that would cost the US its elimination status. The fact that 33 jurisdictions across the country have reported 2026 cases, spanning every geographic region from Alaska to Florida, demonstrates that this is no longer a regional or community-specific problem. It is a national public health emergency unfolding in real time.

US Measles Vaccination Coverage Statistics

Sources: CDC — Measles Cases and Outbreaks (cdc.gov/measles/data-research, April 2026); CDC — VaxView Immunization Coverage Data; WHO Disease Outbreak News — Measles USA, March 2025; NEJM — “Measles 2025” (2025); PMC — “The 2025 United States Measles Crisis: When Vaccine Hesitancy Meets Reality”; CDC MMWR — “Progress Toward Measles Elimination — Worldwide, 2000–2023” (November 2024); WHO Measles Fact Sheet (updated November 2025); ASTHO Blog, January 21, 2026; IDSA — Measles Vaccination Facts (updated March 2026)

The vaccination coverage data is where the root cause of the 2025–2026 measles crisis becomes most visible. The decline from 95.2% kindergartner MMR coverage in 2019–2020 to 92.5% in 2024–2025 seems modest — less than 3 percentage points — but it represents a crossing of the critical 95% herd immunity threshold that mathematically determines whether measles can sustain transmission in a community. Below 95%, the virus finds enough susceptible individuals to keep moving; above 95%, transmission chains collapse before they can grow. What makes the national average figure even more alarming is what it conceals: the analysis published in the New England Journal of Medicine found that 990 of 1,501 US counties studied had MMR coverage below 95%, and 70 counties had coverage below 74% — a level at which major outbreaks are not just possible but effectively guaranteed when the virus arrives. Texas counties at the center of the 2025 Southwest outbreak had coverage as low as 70.5% — figures that would not be out of place in low-income countries with limited health infrastructure.

The trajectory of coverage decline follows a clear timeline: the COVID-19 pandemic disrupted routine childhood immunization starting in 2020, with missed well-child visits translating directly into unvaccinated or under-vaccinated children. Non-medical exemption rates have been rising in parallel, driven by coordinated vaccine hesitancy movements that specifically target school-entry requirements. The 286,000 kindergartners estimated to be unprotected in the 2024–2025 school year are the visible tip of a larger iceberg that includes older children who missed catch-up doses, teenagers whose parents sought exemptions, and adults in certain religious or cultural communities where vaccination uptake has been historically low. The 97% efficacy of the two-dose MMR regimen means the vaccine is not the problem — availability, uptake, and trust are. As the CDC has stated plainly on its official measles data page, the path back to secure elimination status runs directly through restoring and sustaining ≥95% two-dose MMR coverage in every community across the country.

US Measles Elimination Status: History & Current Risk Statistics

Sources: CDC — Measles Cases and Outbreaks (cdc.gov/measles/data-research, April 16, 2026); CDC — History of Measles (cdc.gov/measles/about/history.html); WHO Disease Outbreak News — Measles USA, March 2025; ASTHO — “Understanding Current US Measles Outbreaks and Elimination Status,” January 21, 2026; KFF — “Measles Elimination Status: What It Is and How the US Could Lose It,” April 2026; CIDRAP Measles Coverage (multiple updates 2026); Johns Hopkins Bloomberg School of Public Health, April 2026; CDC — Manual for Surveillance of Vaccine-Preventable Diseases, Chapter 7

The history of the US measles elimination status is a story of scientific achievement, policy success, and now an unprecedented test of whether that achievement can be sustained. The 2000 declaration was not the starting point but the culmination: the US switched to a two-dose MMR schedule in 1989 after a major outbreak among vaccinated school children exposed gaps in single-dose protection. Over the following decade, coverage climbed, surveillance tightened, and transmission chains were consistently interrupted until the CDC and independent experts agreed the threshold had been met and held for long enough to declare elimination. For over two decades, that status persisted through small outbreaks — including the alarming 2019 New York City outbreak that reached 1,274 cases and came within months of triggering a status loss before transmission was finally stopped. The 2019 near-miss was the clearest early warning that the system was under strain. It was not heeded broadly enough.

The current risk to US elimination status is more serious than 2019 by every measurable indicator. The combined case count from January 2025 through early April 2026 exceeds 4,000 confirmed cases across 46 states and jurisdictions — a figure that dwarfs the entire 22-year total of 4,056 cases reported between 2001 and 2022. The PAHO elimination review meeting on April 13, 2026, which formally invited the United States and Mexico to assess their status, is not a routine checkup — it is an institutional signal that the international public health community is preparing to act on what the data is showing. Whether the US retains its status will depend on the CDC’s assessment of whether the 2025 outbreaks across different states represent one linked endemic transmission event or multiple separate introduction chains that were eventually contained. The answer to that question — still being worked through by CDC epidemiologists as of April 2026 — will determine whether the US joins Canada, the UK, and several European nations in officially losing measles elimination status for the first time in a quarter century.

Key Measles Outbreak Locations & State-Level Statistics in the US 2026

Sources: CDC — Measles Cases and Outbreaks (cdc.gov/measles/data-research, updated April 16, 2026); South Carolina Department of Public Health — 2025 Measles Outbreak Update (dph.sc.gov, April 17, 2026); CIDRAP — “South Carolina’s Measles Outbreak Hits 700 Cases” (January 23, 2026); Healthline — “Measles Outbreak 2026” (April 16, 2026); Public Health Communications Collaborative — US Measles Outbreak Communication Tool (April 9, 2026); Wikipedia — Measles Resurgence in the United States (updated April 2026)

The geographic spread of measles in 2025–2026 reveals something important about the nature of the current crisis: this is not a localized phenomenon that can be managed with a targeted regional response. When 45 jurisdictions report cases in a single year — as happened in 2025 — and when 33 states have already reported confirmed cases in just the first 16 weeks of 2026, it indicates that unvaccinated communities exist in sufficient density across virtually every region of the country to sustain transmission. The South Carolina outbreak is the statistical headline, but the underlying story is the nationwide distribution. Starting October 2, 2025 and centered in Spartanburg County, the South Carolina event grew to 997 confirmed cases — a number that took it past the 2019 New York City outbreak to become the largest single US measles outbreak since the elimination declaration. The fact that the South Carolina case total stopped at 997 on March 20, with no new cases reported in the following weeks, offers some cautious optimism that the local outbreak is being contained — but it does not address the 752 additional cases confirmed across the other 32 reporting jurisdictions in 2026.

The age distribution of 2026 cases — with 84% occurring in people ages 0–19 and 25% in children under 5 — points directly to the breakdown in childhood vaccination. These are not adult populations who received vaccines decades ago and have waning immunity. These are children who should have been vaccinated as a matter of routine but were not, either through parental choice, exemption, access barriers, or pandemic-era missed appointments. The 9% hospitalization rate among children under 5 in 2026 (compared to 18% in 2025 at this age group) may reflect some improvement in clinical response, but it remains a sobering reminder that measles is not a mild disease for young children. Pneumonia, encephalitis, and permanent neurological damage are among the known complications of measles infection, and the virus’s capacity to suppress the immune system for months after recovery — a phenomenon known as immune amnesia — creates additional vulnerability to other infectious diseases long after the rash has cleared.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE